Uber could announce a new CEO by mid-week
As Business Insider and other news outlets have reported, Uber's board has been meeting since...
As Business Insider and other news outlets have reported, Uber's board has been meeting since...
Former GOP Arizona state senator is challenging one of President Trump's staunchest Republican critics

London police arrested a second man Sunday in connection with a suspect who drove up to a police van not far from Buckingham Palace then reached for a 4-foot (1.2-meter) sword, an incident detectives called ...
Lebanese soldiers in Islamic State captivity since 2014 are almost certainly dead, a senior security official said on Sunday, just hours after the army announced a ceasefire to hold talks over their fate. The ceasefire halted the fighting in an Islamic State enclave at the Syria-Lebanon border, where the militants have been fighting the Lebanese army on one front and Hezbollah with Syrian troops on the other.
President Donald Trump pardoned America's "toughest sheriff" Joe Arpaio on Friday. He reportedly...
Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection risks and a high price may overshadow the medicine's limited benefits. Keenly awaited clinical trial results released on Sunday showed heart-attack survivors on one of three doses of canakinumab were 15 percent less likely to suffer another major cardiac event than those on a placebo. Novartis had said in June that the drug met its goal in the study but details were only unveiled at European Society of Cardiology meeting in Barcelona.
From Jordan Roy-Byrne: Welcome to the dog days of summer. The low volatility in precious metals continues. Janet Yellen or some other Fed heads said something Friday. Precious Metals sold off but quickly recovered. It appears that not much has… Read more ›